Clinical Trial Update: A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase I study evaluating safety and tolerability of topical CRx-197 formulations in healthy volunteers. Atopic Dermatitis is the listed condition for this trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CRx-197 topical formulation (CRx-197)

Snippet

Sponsor: Zalicus | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED